Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma (ATTAACH)
Pilot Randomized Controlled Trial of Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma (ATTAACH)
Sponsor: Sunnybrook Health Sciences Centre
Terminated
Study terminated due to logistical challenges in conducting the trial.
Other terminated trials from Sunnybrook Health Sciences Centre
Other Atrial Fibrillation trials with similar outcome
A NA clinical study on Atrial Fibrillation and Subdural Hematoma, this trial is terminated or withdrawn. The trial is conducted by Sunnybrook Health Sciences Centre and has accumulated 5 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Dec 2022 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Not Yet Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sunnybrook Health Sciences Centre
For direct contact, visit the study record on ClinicalTrials.gov .